John Tamerius, PhD, has been promoted to senior vice president, clinical/regulatory affairs, at Quidel (San Diego), from his present position as vice president, clinical/regulatory affairs. Tamerius has been with Quidel for 25 years. He has served as vice president, clinical/regulatory affairs since 2005, and previously held a variety of executive roles, including responsibility for research and development and general management of Northern California operations. Quidel is a maker of rapid point-of-care diagnostic tests.

James Corbett has been named president/CEO and a director of Vertos Medical (San Jose, California), a privately held device company focusing on a minimally invasive treatment for lumbar spinal stenosis (LSS). The company also said it has expanded its board to six members by adding Daniel Pelak as a director. Corbett has nearly three decades of leadership experience in the med-tech field, most recently as CEO of ev3, where he led the development of its peripheral/neurovascular device business. He also has held top posts with Home Diagnostics, Boston Scientific and Baxter Healthcare. Pelak has extensive medical device management experience as well, including serving as CEO of InnerPulse and Closure Medical. Vertos Medical has FDA clearance for its MILD (Minimally Invasive Lumbar Decompression) technology, a simple, percutaneous, fluoroscopically-guided treatment for LSS.